Syndrome inflammatoire et déséquilibre d'un diabète de type 2induit par le dobésilate calcium (Doxium®)
Emmanuel Chatelus(Laboratoire National de Référence), Bernard Goichot(Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine), Anne Perrin, S. Vinzio(Groupe Hospitalier Mutualiste de Grenoble), J.L. Schlienger, Martine Alt
Cited by 0
Related Papers
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207